Mitochondria
9
2
2
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
1 terminated out of 9 trials
83.3%
-3.2% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Antecedent Metabolic Health and Metformin Aging Study
Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy
Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT)
Insufficient Oxygenation in Septic Patients
Boosting Performance: The Power of Cranberry Supplementation
BFR and Muscle Mitochondrial Oxidative Capacity
Insufficient Cellular Oxygen in ICU Patients With Anaemia
Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms
Metabolic Mapping to Measure Retinal Metabolism